Influenza vaccination in 2013-2014: Achieving 100% participation

JAMA

Volumn 310, Issue 16, 2013, Pages 1681-1682

  Neuzil, Kathleen M ^a  

^a PATH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HAEMOPHILUS INFLUENZAE TYPE B VACCINE; INFLUENZA VACCINE; PLACEBO; PNEUMOCOCCUS VACCINE;

BACTERIAL PNEUMONIA; CARDIOVASCULAR DISEASE; CORONARY ARTERY DISEASE; DEATH; DRUG EFFICACY; DRUG MEGADOSE; EDITORIAL; EPIDEMIC; HAEMOPHILUS INFLUENZAE TYPE B; HEART MUSCLE ISCHEMIA; HIGH RISK POPULATION; HOSPITALIZATION; HUMAN; IMMUNOGENICITY; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS; INFORMATION DISSEMINATION; MENINGITIS; META ANALYSIS (TOPIC); MORBIDITY; MORTALITY; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); STREPTOCOCCUS PNEUMONIAE; UNITED STATES;

EID: 84886244251     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2013.279207     Document Type: Editorial

References (18)

1. Centers for Disease Control and Prevention. Prevention and control of seasonal influenza vaccines. MMWR Recomm Rep. 2013;62(RR07):1-43.
2. Vesikari T, Knuf M, Wutzler P, et al. Oil-in-water emulsion adjuvant with influenza vaccine in young children. N Engl J Med. 2011;365(15):1406-1416.
3. Ambrose CS, Levin MJ, Belshe RB. The relative efficacy of trivalent live attenuated and inactivated influenza vaccines in children and adults. Influenza Other Respi Viruses. 2011;5(2):67-75.
4. ClinicalTrials.gov. Study of Fluzone high-dose vaccine compared with Fluzone vaccine in elderly adults. http://www.clinicaltrials.gov/ct2/show/ NCT01427309?term=sanofi+and+influenza+vaccine&rank=38. Accessed September 26, 2013.
5. Jackson LA, Jackson ML, Nelson JC, Neuzil KM, Weiss NS. Evidence of bias in estimates of influenza vaccine effectiveness in seniors. Int J Epidemiol. 2006;35(2):337-344.
6. Gessner BD, Brooks WA, Neuzil KM, et al. Vaccines as a tool to estimate the burden of severe influenza in children of low-resourced areas (November 30-December 1, 2012, Les Pensieres, Veyrier-du-Lac, France). Vaccine. 2013;31(32):3222-3228.
7. Cutts FT, Zaman SM, Enwere G, et al Gambian Pneumococcal Vaccine Trial Group. Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia. Lancet. 2005;365(9465):1139- 1146.
8. Gessner BD, Sutanto A, Linehan M, et al. Incidences of vaccine-preventable Haemophilus influenzae type B pneumonia and meningitis in Indonesian children. Lancet. 2005;365(9453):43-52.
9. Udell JA, Zawi R, Bhatt DL, et al. Association between influenza vaccination and cardiovascular outcomes in high-risk patients: ameta-analysis. JAMA. 2013. doi:10.1001/jama.2013.279206.
10. Smeeth L, Thomas SL, Hall AJ, Hubbard R, Farrington P, Vallance P. Risk of myocardial infarction and stroke after acute infection or vaccination. N Engl J Med. 2004;351(25):2611-2618.
11. Warren-Gash C, Smeeth L, Hayward AC. Influenza as a trigger for acutemyocardial infarction or death from cardiovascular disease. Lancet Infect Dis. 2009;9(10):601-610.
12. Govaert TM, Thijs CT, Masurel N, Sprenger MJ, Dinant GJ, Knottnerus JA. The efficacy of influenza vaccination in elderly individuals. JAMA. 1994;272(21):1661-1665.
13. De Villiers PJ, Steele AD, Hiemstra LA, et al LAIV Elderly Study Trial Network. Efficacy and safety of a live, attenuated influenza vaccine in adults 60 years of age and older. Vaccine. 2009;28(1):228-234.
14. Ciszewski A, Bilinska ZT, Brydak LB, et al. Influenza vaccination in secondary prevention from coronary ischaemic events in coronary artery disease. Eur Heart J. 2008;29(11):1350-1358.
15. Phrommintikul A, Kuanprasert S, Wongcharoen W, Kanjanavanit R, Chaiwarith R, Sukonthasarn A. Influenza vaccination reduces cardiovascular events in patients with acute coronary syndrome. Eur Heart J. 2011;32(14):1730-1735.
16. Gurfinkel EP, Leon de la Fuente R, Mendiz O, Mautner B. Flu vaccination in acute coronary syndromes and planned percutaneous coronary interventions (FLUVACS) study. Eur Heart J. 2004;25(1):25-31.
17. Osterholm MT, Kelley NS, Sommer A, Belongia EA. Efficacy and effectiveness of influenza vaccines. Lancet Infect Dis. 2012;12(1):36-44.
18. Centers for Disease Control and Prevention. Flu vaccination coverage, United States, 2012-2013 influenza season. http://www.cdc.gov/flu/fluvaxview/ coverage-1213estimates.htm. Accessed September 30, 2013.